
31.38 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 20.24 Today|||52-Week Range 39.43 | +12.84% Year-to-Date |
Denali Therapeutics Inc. (DNLI) Surges 5.8%: Is This an Indication of Further Gains? Feb 03 / Zacks.com - Paid Partner Content | Bristol Myers Squibb (BMY) Q4 Earnings and Revenues Surpass Estimates Feb 02 / Zacks.com - Paid Partner Content |
Previous close | 31.70 |
Today’s open | 31.32 |
Day’s range | 30.78 - 31.74 |
Volume | 10,475 |
Average volume (3 months) | 778,373 |
Market cap | $4.3B |
Earnings growth (last year) | -466.28% |
Earnings growth (this year) | -6.98% |
Earnings growth (next 5 years) | -11.02% |
Revenue growth (last year) | -85.50% |
P/E ratio | NM |
Price/Sales | 111.38 |
Price/Book | 4.03 |
Today’s change | Today’s % change | |
---|---|---|
CRSPCRISPR Therapeutics ... | +0.24 | +0.43% |
---- | ||
ZLABZai Lab Ltd | -1.09 | -2.72% |
ARWRArrowhead Pharmaceut... | -3.24 | -8.82% |
Next reporting date | February 27, 2023 |
EPS forecast (this quarter) | -$0.79 |
Annual revenue (last year) | $48.7M |
Annual profit (last year) | -$290.6M |
Net profit margin | -597.15% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Francisco, California |